期刊文献+

Research and Development of New Chinese Materia Medica for Treatment of Refractory Hematopathy by Establishment and Application of Multiple Technique Platforms 被引量:7

Research and Development of New Chinese Materia Medica for Treatment of Refractory Hematopathy by Establishment and Application of Multiple Technique Platforms
原文传递
导出
摘要 Research Objective and Overview It is necessary to find effective Chinese materia medica (CMM) for the treatment of refractory hematopathy as commonly used prednisone, androgen and immune suppression agents of tendemonstrate poor efficacy and serious side effects. Research Objective and Overview It is necessary to find effective Chinese materia medica (CMM) for the treatment of refractory hematopathy as commonly used prednisone, androgen and immune suppression agents of tendemonstrate poor efficacy and serious side effects.
作者 高瑞兰
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第2期95-97,共3页 中国结合医学杂志(英文版)
基金 Supported by Australia-China Links Program sponsored by IDP Education Australia (NoⅡ-8) the National Natural Science Foundation of China (No 30070933) the Natural Science Foundation of Zhejiang Province as the key project (No DZ007) State Administration of TCM of China (No 972025)
  • 相关文献

参考文献7

二级参考文献20

共引文献117

同被引文献31

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部